Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
This novel treatment, nearing Phase 1 clinical trials, could help prevent weight regain post-GLP-1 analogue use by mimicking the incretin hormone to suppress appetite and regulate blood sugar, thus aiding in the management of obesity and diabetes
Phosphagenics (ASX:POH) shares were trading 6.9% higher at 15.5 cents as of around 1:30 pm on Wednesday
Almost all are administered subcutaneously, although oral semaglutide is currently available in Spain (see below)
Wipe the stoppers of both vials with fresh alcohol swabs
US$ 24.71
US$ 22.56
US$ 20.82
US$ 23.13
US$ 29.53
US$ 26.20
US$ 25.59
